Brain region-specific enhancement of remyelination and prevention of demyelination by the CSF1R kinase inhibitor BLZ945.

Acta Neuropathol Commun · 2018 · PMC5815182 · PMID 29448957

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

This effect was highly significant only after 2 weeks of BLZ945 treatment (Additional file 1 : Figure S5a, b).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.